AI in Pharma

December 1, 2019

Artificial intelligence (AI) can accelerate decision-making and leverage insights in drug development that have not been used before. Günther Illert, founder of Healthcare Shapers, interviews Janik Jaskolski, CEO of Semalytix, about their innovative approach.

Spotlight

Laboratoires Expanscience

Expanscience, a French independent pharmaceutical and dermo-cosmetics laboratory, generated revenue of € 274.7 million in 2016, of which 54.3% internationally, and employed 1044 employees.

OTHER VIDEOS

Changing the world of drug formulation

video | August 15, 2022

Manufacturing drugs for paediatric applications comes with a unique set of challenges. Notably, the need to counteract the bitterness of active pharmaceutical ingredients, and enhance solubility to reduce the risk of delayed onset of action and local tissue injury....

Watch Now

Denver's SmartTab combines modern technology with everyday drug capsule

video | August 11, 2022

A startup pharmaceutical company in Denver is working on a way to deliver much-needed medication through a high-tech capsule. You're In Good Company with SmartTab....

Watch Now

Pharmacy Management System Project in Python Source Code

video | May 21, 2022

Pharmacy Management System Project in Python Source Code What is Pharmacy Management System Project in Python...

Watch Now

AI accelerated drug discovery

video | May 20, 2022

AI accelerated drug discovery, allowing for a fast-track discovery and repurposing of existing molecule, intelligent clinical design and coupled with in-house manufacturing....

Watch Now

Spotlight

Laboratoires Expanscience

Expanscience, a French independent pharmaceutical and dermo-cosmetics laboratory, generated revenue of € 274.7 million in 2016, of which 54.3% internationally, and employed 1044 employees.

Events